FDA Clinical Data Standards-Setting Likely To Run Longer Than Five Years
Agency’s goal of setting standards for clinical data in 57 therapeutic areas in five years looks unlikely to be met, according to the timelines given by members of the Coalition For Accelerating Standards and Therapies.
You may also be interested in...
Validation rules for standardized clinical trial data terminology could allow sponsors to check their data in the same way FDA does.
Sen. Manchin calls for congressional investigation of “pay to play” allegations; FDA maintains the meetings with industry were for scientific, not regulatory purposes, but the agency is looking into the matter.
Building on the 10-pharma clinical development problem-solving initiative launched in September, J&J, Merck and Lilly are spearheading a databank that will share information on clinical trial sites and investigators, with a primary goal of avoiding redundancy in paperwork and training.